Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Still swinging but not getting those quick engineered dips. SIGA's been my main squeeze lately. Being accumulated nicely.
Not seeing those wild daily swings like we were.
rmz, understand that most states do not report on weekend cases, even for Covid. So, the number reported is more representative of a 3-day total, not one.
But even with that, I agree with "WTF!!!" expression.
Almost 9000 cases in the US since May and 1400 occurred just on this past Monday...WTH!!!
US hits record 1,424 new monkeypox cases in a single day on Monday: Fears grow there may be outbreaks across college campuses as students return to school this month
The United States logged 1,424 new monkeypox cases on Monday, the highest single day total of the outbreak yet
America is approaching 9,000 confirmed cases of the virus - the world's largest outbreak - just as the fall semester begins across the country
Experts fear that behavior on college campuses this fall will open the door for rampant spread of the virus this fall
Over the weekend, former FDA Chief Dr Scott Gottlieb said that the virus could still be contained
https://www.dailymail.co.uk/health/article-11095563/US-records-record-1-424-new-monkeypox-cases-Monday.html?ito=push-notification&ci=uz_bBcYENC&cri=LjS9fuODZC&si=28067494&xi=0944a12c-0e89-4f08-900c-c33469a8e664&ai=11095563
This drug could help treat monkeypox. Some patients have struggled to get it
Ten days into his illness, the drug arrived and the result seemed “miraculous,” Cassara said. Little lesions that had started to spread to his body seemed to freeze their onward march and then scabbed over, he said. The wounds on his face began to shrink. As Cassara began to recover, he wondered: Why had it taken so long to get the medicine that finally eased his suffering?
Siga will pass the fda approval with flying colors!!!!!!!!
https://www.latimes.com/california/story/2022-08-10/monkeypox-tpoxx-treatment-drug-patients-struggle
Investingpioneer: A masterful analysis of SIGA,TPOXX, MPOX_that_beats_all_to-date. This analyst is thoroughly enlightened on this subject as opposed to bloviating, foot-dragging, Pay-for-Approval FDA honchos. Please pass it around.
YES YES YES
"Arguments are made that little to no data is present suggesting efficaciousness in monkeypox. However, it should be noted much of the data from the original trials for TPOXX (on which the FDA based their approval for smallpox) to determine efficacy figures were based on animals infected with monkeypox. For safety testing, human subjects were tested. The data showed sufficient safety."*
* https:// pubmed. ncbi.nlm.nih.gov/31181284/
https://investingpioneer.com/2022/08/10/is-siga-technologies-siga-a-buy-in-the-face-monkeypox/
$SIGA
Califf's FDA: Dilute the vaccine & restrict/delay safe&effective treatment/cure.
SIGA's TPOXX (aka tecovirimat) is the ONLY safe & effective treatment for monkeypox. This anti-viral therapeutic traps the virus in the affected cells and halts their spread, allowing the body's immune system to clear itself of the virus. Patients report fast action in remediating the symptoms.. File it under "Wonder Drug."
$SIGA
Is SIGA Technologies (SIGA) a buy in the face of Monkeypox:
Future Catalysts:
-Announcement of orders from multiple countries.
-Emergency funding and orders (expected within 6-8 weeks [speculation]).
-Release of new real-world data (2-3 months).
-Release of trial data (4-6 months).
-Continued proliferation and rapid growth of monkeypox cases.
Targets:
-Projected courses ordered/preordered internationally (6 months): 3,000,000-5,000,000
-Projected Revenue (6 months): $2,100,000,000-$3,500,000,000
-Project share price: $150-$300
https://investingpioneer.com/2022/08/10/is-siga-technologies-siga-a-buy-in-the-face-monkeypox/
“Within 24 hours, my pain was cut in half, and by 48 hours, it was cut by two-thirds,” Watson said.”
$SIGA TPOXX WINNER$
https://sfstandard.com/public-health/the-pain-was-almost-indescribable-monkeypox-victims-on-agonizing-waits-for-treatment-as-they-fight-red-tape/
for a man that feared to go blind. The doctor gave him TPOXX and he was shocked how fast he recovered......
https://sports.yahoo.com/man-tested-negative-monkeypox-twice-152545307.html
Cool I couldn't make anything there too late ....
How stupid is the FDA ? They just gave EUA approval to a vaccine at full dosage already has breakthrough infections. But the now want to give 1/10 of that to suckers, I mean patients. But they fail to grant EUA to TPOXX, which has already shown effectiveness for monkeypox to animals in trials with universally good results in the last month or two. Don’t expect an EUA for months; probably only after the trial is completed.
i grab my profit
And the close
Epic Fail wave 5 of the ELLIOTT WAVE...
195 countries x $26m=$5.07b coming soon!!!
0.15 WOOHOOOOOO I bought more SIGA on dip weeeeeeee
SIGA WOOHOOOOOO Not 0.14 going to $1
Ttoo exploring...Wtf siga has product and a chart in wave 5 of the ELLIOTT WAVE
winner$$$$ TOPXX
I 100% believe the EU order has happened but terms state it can't be announced until distribution is finished. Labeling (which is significant) have to be done in 24 languages and as odd as it sounds, is the last thing holding up the announcement- I know this sounds crazy!!!!!!!!
tecovirimat label popped up again but this time in a new language:
https://www.ema.europa.eu/en/documents/all-authorised-presentations/tecovirimat-siga-epar-all-authorised-presentations_hr.pdf
These are the people who took TPOXX to cure their monkeypox...
Our thoughts on SIGA summed up into a video
https://www.tiktok.com/@moonapehodl/video/7129588154801278254
Good find pre-Gomez. When the other treatments failed,_TPOXX_(ST-246)_to_the_rescue. Got that, Califf?
Healthcare & Pharma
March 20, 2007
Toddler improving on experimental smallpox drug
By Julie Steenhuysen
CHICAGO (Reuters) - An experimental pill appears to be helping a toddler who had a near-fatal skin reaction to his father’s smallpox shot, doctors said on Monday.
The drug, an antiviral made by Siga Technologies called ST-246, worked when more conventional treatment failed, the doctors said.
The 2-year-old, still in critical condition at the University of Chicago’s Comer Children’s Hospital, developed the rare serious reaction called eczema vaccinatum after being with his father, a soldier vaccinated for deployment in Iraq.
“He’s making slow improvement every day. He’s still in the pediatric intensive care unit,” said Dr. John Marcinak, pediatric infectious disease specialist at the hospital.
Marcinak said the rash now consumes 80 percent of the child’s body. “He’s lost a lot of the superficial areas of his skin called the epidermis. There is still a lot of healing that needs to be done,” he said.
The child, from Indiana, was admitted to the hospital on March 3, and the U.S. Centers for Disease Control and Prevention confirmed he was infected with the virus used in the smallpox vaccine.
Smallpox vaccines do not use the smallpox virus, but instead use a related virus called vaccinia that is weakened but can still infect some people.
The child was given an intravenous form of vaccinia immune globulin -- developed in the 1960s to treat complications of smallpox vaccinations. He also received a treatment of the antiviral drug cidofovir, made by Gilead Sciences Inc.
But he was still failing. His mother also had a rash but was not ill and his father reported no adverse reaction.
By then, Marcinak and his team were having daily conference calls with the CDC, health departments, the Department of Defense and the National Institutes of Health. During one, the CDC suggested the hospital try the experimental drug. [ed. Cheers to CDC]
The drug has helped monkeys infected with smallpox, but its effectiveness has not been proven in humans.
Seeing the drug used in an infected patient presents a rare opportunity for Siga. For ethical reasons, the drug can only be tested in healthy volunteers.
“I think we can feel reasonably confident ... that this drug is contributing to the child’s recovery,” Siga Chief Executive Dr. Eric Rose said in a telephone interview.
The child’s case is the first report of eczema vaccinatum since vaccination against smallpox resumed in 2002, CDC pox virus expert Dr. Inger Damon said. She said he may already have had eczema -- which makes patients especially vulnerable to the serious reaction.
[ed. eczema vaccinatum is a potential side efffect of smallpox vaccination although it has occurred followiing vaccination for chicken pox. Interestingly, those who are non-asthmatic and contract chicken pox as children are far less likely to develop eczema & asthma later on, as compared to those who were innoculated against chicken pox.] https://www.foxnews.com/health/chickenpox-may-protect-against-asthma-skin-condition
The smallpox virus once killed 30 percent of its victims, and disfigured many others. A global vaccination campaign eradicated the disease in 1979.
But some samples of smallpox remain in government freezers and experts believe it could be used as a biological weapon. The United States resumed vaccinating some people in 2002, including 40,000 civilian health workers and hundreds of thousands of military personnel.
Rose said the company hopes to have the drug approved for sale by 2009. SIGA shares closed up nearly 14 percent on NASDAQ on Monday, at $5.15 a share.
https://www.reuters.com/article/us-smallpox-vaccine/toddler-improving-on-experimental-smallpox-drug-idUSN1953739120070320
$SIGA
TOPXX It hasn't caused any serious or adverse affects to any human patients who have taken it, and there is now much more evidence of it's efficacy in treating monkeypox patients who have reported vast improvement in a short time after receiving it. As the only available treatment in the world for monkeypox, I don't see how this won't be approved. It already is in the EU and UK for monkeypox treatment.
08-08-2022 Senate narrowly confirms Robert Califf to head_FDA_over_Manchin_pushback
BP apparently got their boy,
https://nypost.com/2022/02/15/senate-narrowly-confirms-robert-califf-to-head-fda/
Excerpts
He was nominated to the position by the President Biden in November. Califf will be taking over from Acting FDA Commissioner Janet Woodcock. The agency, which has lacked a permanent leader since Biden took office, has been under fire over the past year for not acting fast enough to approve possibly life-saving vaccines and treatments for the coronavirus.
Califf, a longtime cardiology professor at Duke University, served in the role (FDA Commisioner) for a short 11 months and was replaced by former President Donald Trump at the start of his administration.
The Senate confirmed President Biden’s nominee 50-46, after Califf received opposition from Sen. Joe Manchin (D-WV), who argued the doctor bore “a great deal of responsibility” for massive drug overdose deaths that have happened since his last tenure in the position.
While many Democrats supported Califf for the position, he has drawn scrutiny over his past ties to the pharmaceutical industry. In November, Manchin blasted his nomination as an “insult to the many families and individuals who have had their lives changed forever” by opioid addiction.
Democratic Sens. Ed Markey of Massachusetts, Richard Blumenthal of Connecticut and Maggie Hassan of New Hampshire, as well as independent Sen. Bernie Sanders of Vermont joined Manchin in voting against, citing his ties to the pharmaceutical industry.
“I could not support Dr. Califf’s nomination in 2016 and I cannot support it now," Manchin said. "Nothing that Dr. Califf has said or done has led me to believe he will operate the FDA any differently than he did during his previous tenure."
$SIGA
https://nypost.com/2022/02/15/senate-narrowly-confirms-robert-califf-to-head-fda/
The dip this morning is so far a higher low from Friday's morning dip
interest in SIGA will remain high - might even close green by end of day!!!
relax$
"read the story" Toddler improving on experimental smallpox drug 2007
The drug, an antiviral made by Siga Technologies called ST-246, worked when more conventional treatment failed, the doctors said.
https://www.reuters.com/article/us-smallpox-vaccine/toddler-improving-on-experimental-smallpox-drug-idUSN1953739120070320
winner$$$$$$$
We needed to back fill about 4 mil in the mid 22’s, we just completed that fill. We will move back into 24’s today
Not sure if you guys seen this video...
USG regulators like FDA--who can make or break companies even entire industries to the tune of hundreds of millions or X billions of dollars, not to mention affecting the health and well-being of millions for better or worse--should be required to release their investment activities including that of their spouses. Even that would likely not be enough to root out lucrative conflicts on interest.
TPOXX
$SIGA
Cardiff has to protect his “investors”
$1.50 drop in 10 minutes ?
Is FDA Commish Cardiff this misinformed? "We think it's (TPOXX) going to be effective in monkeypox, but we have no proof yet." (media call August 7, 2022)
Get out of your insulated luxury cocoon, tone-deaf Dr. Cardiff. The proof is out there in spades including USG data. So you don't trust the CDC or medical doctors clamoring for it nor TPOXX success stories piling up by the day. More than enough to warrant an EUA not to mention the work by SIGA at Oxford and the UK studies that clinched approval. Never heard of EU-EMA, Ontario Ministry of Health, or UK MHRA?
$SIGA
remember , $SIGA has the MP treatment..multibagger$$$$$
A doctor in Israel was infected while seeing patients:
https://www.timesofisrael.com/medical-staff-call-to-be-vaccinated-against-monkeypox-after-doctor-infected/
Lot of talk here about approval taking months. Gomez as we know is very conservative with his predictions, especailly about timing; but here's what Gomez actually said in his CC, when asked about the timing of an approval.
"It is hard to predict because -- it could be based on the final data, if there was an acceleration of reviews under an EUA, whether it's before or middle or after that clinical trial, it's hard to predict the timing."
Just to repeat. Even the close-to-the-vest Gomez is saying that an EUA could come BEFORE the clinical trial (which starts soon). It could also come in the middle, presumably through an interim review.
So anyone who says with surety that an Emergency Use Approval for Tpoxx will definitely have to wait for the data to come from the trials is talking through their tinfoil hat. It could happen any time.
Trials? Big Pharma owned FDA'ers should be put on_trial_not_wonder_drug_TPOXX.
FDA Executive Officer
"So they (BP) give you (FDA) more money, yes, that's great and it increases the chance of approval."
"Almost a billion dollars a year going into FDA's budget from the people we regulate."
https://www.projectveritas.com/video/fda-executive-officer-exposes-close-ties-between-agency-and-pharmaceutical/
Biden wants to inoculate as many people as possible," the video shows Cole saying before jumping ahead in the video. "So you have to get an annual shot. I mean, it hasn't been formally announced yet, so you don't want to like, rile everyone up."
"The vaccine, it wanes, your ability to fight it wanes so the three will bolster your system and then there will be an annual one just like the flu shot," Cole is heard saying.
"The drug companies, the food companies, the vaccine companies.... so they pay us hundreds of millions dollars a year to hire and keep the reviewers to approve their products," Cole said in another part of the video. "If they can get every person required to get an annual vaccine that is a recurring return of money going into their company."
The Project Veritas leader also alleged Cole "rubber-stamped" the approval of emergency use authorization of toddler Covid vaccines, saying the move was motivated by the "fountain of revenue that goes into the FDA."
"The video talks about the fountain of money, the fountain of revenue, that goes into the FDA. The money they get from these pharmaceutical companies makes it more likely to approve their products," O'Keefe explained.
https://www.ibtimes.sg/who-christopher-cole-fda-executive-caught-project-veritas-hidden-camera-saying-biden-will-force-62820
$SIGA
Monkeypox at a daycare was ‘only a matter of time,’ expert says. Next up: pools, sports, schools:
https://fortune.com/2022/08/07/can-monkeypox-spread-at-daycares-schools-colleges-prisons-congregate-settings-pool-contact-sports/
New Strain monkeypox detected in India:
https://news.abplive.com/health/monkeypox-in-india-icmr-niv-study-reveals-virus-strain-a-2-in-two-uae-returnees-who-tested-positive-1546823
Followers
|
49
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1361
|
Created
|
09/25/06
|
Type
|
Free
|
Moderators |
SIGA Technologies, Inc. (Nasdaq: SIGA) is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Our lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |